Pharma stocks to invest in based on R&D spending levels

August 28th, 2017

Continued research and development (R&D) is a must in the pharmaceutical industry as even the biggest blockbuster drugs eventually lose patent exclusivity or face new and improved competition. However throwing money into R&D alone doesn’t guarantee success, it is vital to also make smart investments into companies which are successfully incorporating R&D into their business activities. The following five pharma stocks are recommended for investors to own based on R&D spending levels.

  1. Merck

Merck invested $6.8 billion into R&D in 2016, this being slightly over 19% of the company’s total pharmaceutical revenue. Market research conducted by EvaluatePharma, projects that the company will hold onto this spot until 2022.

  1. Johnson & Johnson

In 2016 Johnson & Johnson has $7 billion R&D spending which reflects 22% of the company’s total pharmaceutical sales. EvaluatePharma predicts that J&J will move up to third position for its R&D spending by 2022.

  1. Pfizer

Pfizer is the world’s leader in prescription drug sales and ranks third for R&D investments. Pfizer spent $7.8 billion on R&D in 2016, which is roughly 17% of total pharma sales. EvaluatePharma predicts that Pfizer will drop in its ranking by 2022 for both prescription drug sales and R&D spending.

  1. Novartis

Novartis invested $7.9 billion into pharmaceutical R&D in 2016, which comprised a little over 19% of total pharmaceutical sales. EvaluatePharma also predicts that Novartis will keep its ranking for R&D spending until 2022.

  1. Roche

In the number one spot comes the Swiss Pharmaceutical giant Roche. Roche invested $8.7 billion in pharmaceutical R&D in 2016, this represents 22% of Roche’s total prescription drug sales in 2016 and is the most any big pharma company has invested. It is projected that the Swiss healthcare company will retain this number one position until at least 2022.

lab-217041_960_720

In addition to securing a competitive position in the market, investing into R&D also allows businesses to claim an R&D Tax Incentive. The R&D Tax Incentive reduces the cost and risk of undertaking R&D activities for your business and supports companies doing eligible work to create new or improved products, processes and services by reducing their tax. To find out more contact a Swanson Reed R&D Tax advisor today, we look forward to guiding you through the R&D process.

Categories

Archives

Swanson Reed - Specialist R&D Tax Advisors
Swanson Reed - Specialist R&D Tax Advisors
39 Google reviews
Daniel McGregor
Daniel McGregor
2022-08-11
I have been using Swanson Reed for my clients for more than a decade. Having a specialist firm that can provide practical and commercial advice that produces real outcomes is very important and we have received great feedback from our clients. Highly recommended.
John
John
2022-06-15
Damian and the rest of the team at Swanson Reed have been supporting us for several years. We always appreciate their insights, expertise, and efforts.
Rueben Rajasingam
Rueben Rajasingam
2022-06-06
Experienced responsive Team. They have been a great help to me and my company navigate the R&D tax claim process and have provided invaluable advice.
Enrique Esquivel
Enrique Esquivel
2022-06-06
Damian and the team at Swanson Reed have been extremely helpfully and professional during all of our consultations. Highly recommended.
Jess at Y&C
Jess at Y&C
2022-06-03
Anatole Kononewsky
Anatole Kononewsky
2022-06-02
The Swanson Reed team have provided our company with exceptional professional advice and assistance for all of our R&D claims for many years - have always achieved great results with excellent value for their services.
Payam Toloo
Payam Toloo
2022-06-02
Damian Smyth and his team are very helpful, supportive and experts in their field of R&D Tax claims. I'm always happy with the work they do and been a customer of their for over 5 years.
Melissa Doddy
Melissa Doddy
2022-05-31
The Team at Swanson Reed are very experienced R&D Tax Advisors and gave us ongoing support with all of our R&D Claims, the consultants ensured we were always working with current legislative guidelines, gave us assistance with compiling technical and government documentation and went out their way to ensure they were with us for the entire process from beginning to end. Highly recommended to anyone who needs assistance with working through what can at times be a daunting process.
Gary Watson
Gary Watson
2022-05-31
We can highly recommend Swanson and Reed as an R & D accountant. We have worked with them for several years now as they make our R & D claim so easy and communicate quickly with both us and our accountant.
Rob van den Bergh
Rob van den Bergh
2022-05-31
Always professional.